Arterial Stiffness in Mild Primary Hyperparathyroidism
The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Abstract
When primary hyperparathyroidism was a more symptomatic disease, it was often associated with increased cardiovascular risk. As the clinical manifestations of the disease have changed to a milder, more asymptomatic disorder, investigation is shifting to more subtle cardiovascular abnormalities. We measured arterial stiffness in 39 patients with mild primary hyperparathyroidism [serum calcium, 2.66 +/- 0.2 mmol/liter (10.7 +/- 0.6 mg/dl); PTH, 21.7 +/- 9.5 pmol/liter (89 +/- 39 pg/ml)] and in 134 controls. Arterial stiffness was measured mathematically at the radial artery with a noninvasive device as the "augmentation index" (AIx). The AIx measures the difference between the second and first systolic peaks in the pressure waveform and correlates with increased cardiovascular risk. When physiological variables affecting augmentation index and potentially confounding cardiovascular risk factors (age, gender, heart rate, height, blood pressure, diabetes mellitus, smoking, and hyperlipidemia) were adjusted for, primary hyperparathyroidism was an independent predictor of increased augmentation index (B = 3.37; P < 0.03). A matched-pair analysis showed that 15% of the variance in AIx was uniquely accounted for by the presence of primary hyperparathyroidism. The presence of primary hyperparathyroidism was a stronger predictor of elevated AIx than age, gender, smoking, hypertension, hyperlipidemia, or diabetes mellitus. AIx was also directly correlated with evidence of more active parathyroid disease, including higher PTH levels (r = +0.42; P < 0.05) and lower bone mineral density at the distal one-third radius (r = -0.33; P < 0.05). The diagnosis of primary hyperparathyroidism was therefore an independent predictor of increased AIx, an early measure of arterial stiffness, and the increase was associated with evidence of more active parathyroid disease.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
O'Leary, D. H., Polak, J. F., Kronmal, R. A., Manolio, T. A., Burke, G. L., & Wolfson, S. K. (1999) · New England Journal of Medicine · doi:10.1056/nejm199901073400103 · Cited by 4,685
Pauca, A. L., O’Rourke, M. F., & Kon, N. D. (2001) · Hypertension · doi:10.1161/hy1001.096106 · Cited by 1,179
Effects of age and aerobic capacity on arterial stiffness in healthy adults.
Vaitkevicius, P. V., Fleg, J. L., Engel, J. H., O'Connor, F. C., Wright, J. G., Lakatta, L. E., Yin, F. C., & Lakatta, E. G. (1993) · Circulation · doi:10.1161/01.cir.88.4.1456 · Cited by 1,083 · cited 2×
“In addition, a younger control group was used, in whom the AIx might be lower simply as a function of age (11).”
MethodResultArterial stiffness, wave reflections, and the risk of coronary artery disease
Weber, T., Auer, J., O’Rourke, M. F., Kvas, E., Lassnig, E., Berent, R., & Eber, B. (2004) · Circulation · doi:10.1161/01.cir.0000105767.94169.e3 · Cited by 1,081
Reproducibility of pulse wave velocity and augmentation index measured by pulse wave analysis
Wilkinson, I. B., Fuchs, S. A., Jansen, I. M., Spratt, J. C., Murray, G. D., Cockcroft, J. R., & Webb, D. J. (1998) · Journal of Hypertension · doi:10.1097/00004872-199816121-00033 · Cited by 924 · cited 1×
“Reproducibility of the AIx using the SphygmoCor apparatus was determined as described previously (22).”
MethodKARAMANOGLU, M., O'ROURKE, M. F., AVOLIO, A. P., & KELLY, R. P. (1993) · European Heart Journal · doi:10.1093/eurheartj/14.2.160 · Cited by 873
Salomaa, V., Riley, W., Kark, J. D., Nardo, C., & Folsom, A. R. (1995) · Circulation · doi:10.1161/01.cir.91.5.1432 · Cited by 582
Arterial Stiffness Increases With Deteriorating Glucose Tolerance Status: The Hoorn Study
Henry, R. M. A., Kostense, P. J., Spijkerman, A. M. W., Dekker, J. M., Nijpels, G., Heine, R. J., Kamp, O., Westerhof, N., Bouter, L. M., & Stehouwer, C. D. A. (2003) · Circulation · doi:10.1161/01.cir.0000065222.34933.fc · Cited by 471 · cited 1×
“Increased AIx occurs in diabetes mellitus and hypercholesterolemia, probably as a result of alterations in the arterial wall elastin and collagen (14, 15).”
BackgroundIncreased central pulse pressure and augmentation index in subjects with hypercholesterolemia
Wilkinson, I. B., Prasad, K., Hall, I. R., Thomas, A., MacCallum, H., Webb, D. J., Frenneaux, M. P., & Cockcroft, J. R. (2002) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(02)01723-0 · Cited by 448 · cited 1×
“Increased AIx occurs in diabetes mellitus and hypercholesterolemia, probably as a result of alterations in the arterial wall elastin and collagen (14, 15).”
BackgroundKelly, R. P., Millasseau, S. C., Ritter, J. M., & Chowienczyk, P. J. (2001) · Hypertension · doi:10.1161/01.hyp.37.6.1429 · Cited by 393 · cited 2×
“Other factors that can influence AIx include heart rate and height (9, 10).”
BackgroundHeart rate dependency of pulse pressure amplification and arterial stiffness
Wilkinson, I. B., Mohammad, N. H., Tyrrell, S., Hall, I. R., Webb, D. J., Paul, V. E., Levy, T., & Cockcroft, J. R. (2002) · American Journal of Hypertension · doi:10.1016/s0895-7061(01)02252-x · Cited by 357 · cited 2×
“Other factors that can influence AIx include heart rate and height (9, 10).”
Background(1996) · PubMed · Cited by 330
Gender-Related Differences in the Central Arterial Pressure Waveform
Hayward, C. S., & Kelly, R. P. (1997) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(97)00378-1 · Cited by 323 · cited 1×
“Other factors known to increase AIx are female sex (16), smoking (17), and hypertension (18).”
BackgroundAugmentation index as a measure of peripheral vascular disease state
Nichols, W. W., & Singh, B. M. (2002) · Current Opinion in Cardiology · doi:10.1097/00001573-200209000-00016 · Cited by 304
Survival after the Diagnosis of Hyperparathyroidism: A Population-based Study
Wermers, R. A., Khosla, S., Atkinson, E. J., Grant, C. S., Hodgson, S. F., O’Fallon, W. M., & Melton, L. J. (1998) · The American Journal of Medicine · doi:10.1016/s0002-9343(97)00270-2 · Cited by 251
Cardiac Abnormalities in Patients with Primary Hyperparathyroidism: Implications for Follow-Up
Stefenelli, T., Abela, C., Frank, H., Koller-Strametz, J., Globits, S., Bergler-Klein, J. K., & Niederle, B. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.82.1.106 · Cited by 238 · cited 1×
“Tobacco use 3 (8) 4 (3) Hypertension 15 (39) 86 (64) Hyperlipidemia 15 (39) 38 (28) Diabetes mellitus 3 (8) 11 (8) Antihypertensive medications 12 (31) 44 (33)”
Increased risk of death from primary hyperparathyroidism — an update
Hedbäck, & Odén (1998) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.1998.00289.x · Cited by 230
Left ventricular hypertrophy in primary hyperparathyroidism. Effects of successful parathyroidectomy
Piovesan, A., Molineri, N., Casasso, F., Emmolo, I., Ugliengo, G., Cesario, F., & Borretta, G. (1999) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1999.00651.x · Cited by 220
Unfavorable effect of smoking on the elastic properties of the human aorta
Stefanadis, C., Tsiamis, E., Vlachopoulos, C., Stratos, C., Toutouzas, K., Pitsavos, C., Marakas, S., Boudoulas, H., & Toutouzas, P. (1997) · Circulation · doi:10.1161/01.cir.95.1.31 · Cited by 177 · cited 1×
“Other factors known to increase AIx are female sex (16), smoking (17), and hypertension (18).”
BackgroundNilsson, I., Li, Y., Lundgren, E., Rastad, J., & Ekbom, A. (2002) · PubMed · Cited by 142
Effect of chronic hypercalemia on the heart. An analysis of 18 necropsy patients
Roberts, W. C., & Waller, B. F. (1981) · The American Journal of Medicine · doi:10.1016/0002-9343(81)90163-7 · Cited by 137 · cited 1×
“ated with increased cardiovascular risk (1, 2).”
Augmentation of Central Arterial Pressure in Mild Primary Hyperparathyroidism
Smith, J. C. (2000) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.85.10.3515 · Cited by 135 · cited 1×
“Tobacco use 3 (8) 4 (3) Hypertension 15 (39) 86 (64) Hyperlipidemia 15 (39) 38 (28) Diabetes mellitus 3 (8) 11 (8) Antihypertensive medications 12 (31) 44 (33)”
Nilsson, I., Åberg, J., Rastad, J., & Lind, L. (1999) · Surgery · doi:10.1067/msy.2099.101422 · Cited by 123 · cited 1×
“In populations in which the serum calcium did not extend to the markedly abnormal range, it was shown, in contrast, that carotid intima-medial thickness is not affected by PHPT (4, 6, 32, 33).”
BackgroundBarletta, G., De Feo, M. L., Del Bene, R., Lazzeri, C., Vecchiarino, S., La Villa, G., Brandi, M. L., & Franchi, F. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.5.6514 · Cited by 92 · cited 1×
“In populations in which the serum calcium did not extend to the markedly abnormal range, it was shown, in contrast, that carotid intima-medial thickness is not affected by PHPT (4, 6, 32, 33).”
BackgroundNuzzo, V., Tauchmanovà, L., Fonderico, F., Trotta, R., Fittipaldi, M. R., Fontana, D., Rossi, R., Lombardi, G., Trimarco, B., & Lupoli, G. (2002) · European Journal of Endocrinology · doi:10.1530/eje.0.1470453 · Cited by 82 · cited 1×
“Tobacco use 3 (8) 4 (3) Hypertension 15 (39) 86 (64) Hyperlipidemia 15 (39) 38 (28) Diabetes mellitus 3 (8) 11 (8) Antihypertensive medications 12 (31) 44 (33)”
Impairment of endothelium-independent vasodilation in patients with hypercalcemia
Neunteufl, T. (1998) · Cardiovascular Research · doi:10.1016/s0008-6363(98)00177-1 · Cited by 75
Parathyroid adenomas and cardiovascular risk.
Garcia de la Torre, N., Wass, J. A. H., & Turner, H. E. (2003) · Endocrine-related cancer · doi:10.1677/erc.0.0100309 · Cited by 73 · cited 1×
“Symptomatic PHPT has been associated with vascular and myocardial calcification, arrhythmias, hypertension, and left ventricular hypertrophy (24) (25).”
BackgroundKosch, M., Hausberg, M., Vormbrock, K., Kisters, K., Rahn, K. H., & Barenbrock, M. (2000) · American Journal of Hypertension · doi:10.1016/s0895-7061(00)00248-x · Cited by 70 · cited 4×
“77 3328 J Clin Endocrinol Metab, June 2005, 90(6):3326–3330 Rubin et al.”
BackgroundInfluentialJournal of Bone and Mineral Research
Ljunghall, S., Jakobsson, S., Joborn, C., Palmér, M., Rastad, J., & Åkerström, G. (1991) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650061423 · Cited by 62
Ultrasound Evaluation of Carotid Artery in Primary Hyperparathyroidism
Fallo, F., Camporese, G., Capitelli, E., Andreozzi, G. M., Mantero, F., & Lumachi, F. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-021837 · Cited by 56 · cited 1×
“,(34) that study was limited in the scope of the analysis of the carotid artery.”
BackgroundKosch, M., Hausberg, M., Barenbrock, M., Posadzy-Małaczyńska, A., Kisters, K., & Rahn, K. (2001) · PubMed · Cited by 44
Tanokuchi, S., Okada, S., & Ota, Z. (1995) · Journal of International Medical Research · doi:10.1177/030006059502300603 · Cited by 24
Duprez, D. A., Buyzere, M. D., Verloove, H., Kaufman, J., Hoecke, M. J. V., & Clément, D. (1996) · PubMed · Cited by 21
Parathyroid hormone in coronary artery disease — Results of a prospective study —
Herrmann, G., Hehrmann, R., Scholz, H. C., Atkinson, M. J., Lichtlen, P. R., Mühlen, A. V. Z., & Hesch, R. D. (1986) · Journal of Endocrinological Investigation · doi:10.1007/bf03346923 · Cited by 20 · cited 1×
“ated with increased cardiovascular risk (1, 2).”
Physiologic Actions of PTH and PTHrP
Bringhurst, F. R. (2001) · Elsevier eBooks · doi:10.1016/b978-012098651-4/50016-x · Cited by 8
D’Agostino (1998) · doi:10.1002/(sici)1097-0258(19981015)17:19<2265::aid-sim918>3.0.co;2-b
Cited by
Silverberg, S. J., Lewiecki, E. M., Mosekilde, L., Peacock, M., & Rubin, M. R. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-1760 · Cited by 688
Self-citationWalker, M. D., & Silverberg, S. J. (2018) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2017.104 · Cited by 566
Self-citationAmbrogini, E., Cetani, F., Cianferotti, L., Vignali, E., Banti, C., Viccica, G., Oppo, A., Miccoli, P., Berti, P., Bilezikian, J. P., et al. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-0219 · Cited by 404
Self-citationSilverberg, S. J., Clarke, B. L., Peacock, M., Bandeira, F., Boutroy, S., Cusano, N. E., Dempster, D., Lewiecki, E. M., Liu, J.-M., Minisola, S., et al. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-1415 · Cited by 378
Self-citationBollerslev, J., Jansson, S., Mollerup, C. L., Nordenström, J., Lundgren, E., Tørring, O., Varhaug, J.-E., Baranowski, M., Aanderud, S., Franco, C., et al. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-1836 · Cited by 368
“In a recent study of patients with mild pHPT, the diagnosis was associated with increased arterial stiffness (8), but the clinical relevance of these data is not known nor are the effects of successful parathyroid surgery on this parameter.”
Background
Metadata
- Authors
- Rubin, M. R., Maurer, M. S., McMahon, D. J., Bilezikian, J. P., & Silverberg, S. J.
- Affiliations
- Columbia University (US)
- Corresponding author
- Silverberg, Shonni J.
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2005-06
- Volume
- 90
- Issue
- 6
- Pages
- 3326-3330
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2111131646
- Cited by
- 145
- References
- 36
- Citations by year
- 2026: 2 · 2025: 3 · 2024: 2 · 2023: 3 · 2022: 4 · 2021: 6 · 2020: 6 · 2019: 6 · 2018: 8 · 2017: 7 · 2016: 1 · 2015: 9 · 2014: 9 · 2013: 14 · 2012: 20
- FWCI
- 4.33
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK032333, R01DK066329)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Health and Disease Prevention
- Health Sciences › Medicine › Nephrology › Parathyroid Disorders and Treatments
- Health Sciences › Medicine › Orthopedics and Sports Medicine › Bone health and osteoporosis research
- Keywords
- primary hyperparathyroidism, arterial stiffness, augmentation index, cardiovascular risk, parathyroid hormone, bone mineral density, radial artery
- MeSH terms
- Aged, Blood Pressure, Brachial Artery, Female, Heart Rate, Humans, Hyperparathyroidism, Male, Middle Aged, Pulse, Reference Values, Regression Analysis, Systole
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.